Tus-Pharmaceutical Group Co., Ltd. (SHE:000590)
12.04
+0.04 (0.33%)
Sep 11, 2025, 2:45 PM CST
Tus-Pharmaceutical Group Market Cap
Tus-Pharmaceutical Group has a market cap or net worth of 2.87 billion as of September 11, 2025. Its market cap has increased by 118.58% in one year.
Market Cap
2.87B
Enterprise Value
2.79B
Revenue
338.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.04
Market Cap Chart
Since April 27, 2006, Tus-Pharmaceutical Group's market cap has increased from 572.54M to 2.87B, an increase of 401.91%. That is a compound annual growth rate of 8.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 2.86B | 67.93% |
Dec 31, 2024 | 1.70B | -20.65% |
Dec 29, 2023 | 2.15B | 0.22% |
Dec 30, 2022 | 2.14B | -9.51% |
Dec 31, 2021 | 2.37B | 16.51% |
Dec 31, 2020 | 2.03B | -29.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 481.32B |
WuXi AppTec | 322.70B |
Shenzhen Mindray Bio-Medical Electronics | 299.98B |
Sichuan Biokin Pharmaceutical | 153.98B |
Shanghai United Imaging Healthcare | 129.81B |
Zhangzhou Pientzehuang Pharmaceutical., | 124.16B |
Aier Eye Hospital Group | 121.77B |
Yunnan Baiyao Group Co.,Ltd | 107.48B |